GLP-1 drugs expand to heart failure, addiction and aging trials
GLP-1 drugs like Ozempic are in trials for addiction, heart failure, and biological aging, with non-diabetes applications tripling in recent years.
1
Stories per day · 30 days
2 RSS
2 stories, newest first · one card per story
Stories tagged #aging
AI-designed drug appears to turn back the body's biological clock in early trial
Insilico Medicine's AI-designed drug rentosertib showed reduced predicted biological age in IPF trial blood analysis, published in Nature Biotechnology.
1